Minority Women Get Worse Breast Cancer Care.
Minority Women Get Worse Breast Cancer Care, Irrespective of Tumor Type: Study: – TUESDAY, Oct. 13, 2015 – – Regardless of the type or stage of breast cancer, minority women will be diagnosed in the condition than white women later, and they are less inclined to receive recommended treatments also, a fresh study shows. While prior research have found such disparities before, the new study finds that it is present ‘across all breast tumor subtypes,’ study lead author Lu Chen, a researcher in the public health sciences division at Fred Hutchinson Cancer Research Center in Seattle, said in a information release from the American Association for Cancer Research . The analysis received funding from the U.S. National Tumor Institute and was published Oct. 13 in the journal Cancers Epidemiology, Biomarkers & Prevention.Agilent SurePrint G3 Exon Microarrays enable experts to recognize both gene-level and exon-level expression changes within a experiment to fully capture subtle but important biological changes. RNA is ready for hybridization using Agilent’s Low Insight Quick Amp WT labeling package for entire transcript labeling. Agilent’s GeneSpring GX 11.5 bioinformatics system increases productivity even even more by helping investigators analyze gene-level splicing and data indexes simultaneously. ‘Exon level arrays represent a significant step up in our ability to interrogate the genome in more detail than traditional 3 primary biased arrays,’ stated early access user Stuart Pepper, mind of the Cancer Study U.K.